
Children receiving 50 nmol PVX108 increased their tolerated peanut dose 2.4-fold, with no treatment-related anaphylaxis in the phase 2 trial.
Peter S. Moskowitz, MD, Executive Director and Career and Life Coach for medical professionals at the Center for Professional and Personal Renewal, Clinical Professor at Stanford University School of Medicine, Palo Alto, CA, gives advice to physicians on personal and professional growth.






